Skip to content

Analysis of Salivary Constituents of Elderly Patients with Gingivitis After Use of Dentifrice Incorporated with Brazilian Red Propolis

Analysis of Salivary Biomarkers in Elderly Patients with Gingivitis After Use of 1% Brazilian Red Propolis Based Dentifrice: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-5t258m
Enrollment
Unknown
Registered
2020-07-09
Start date
2020-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival diseases

Interventions

In the present study, 80 elderly participants with gingivitis will be selected, will receive removal of the dental biofilm and will be randomized into four groups through the excel program. Group 1 wi
Other
E06.761.726.794

Sponsors

Universidade Federal do Ceará
Lead Sponsor
Universidade Federal do Ceará
Collaborator

Eligibility

Age
66 Years to 100 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers; both genders; presence of gingivitis; age over 65 years; presence of at least five dental elements.

Exclusion criteria

Exclusion criteria: Smoking volunteers; history of alcohol or drug abuse, presence of cognitive problems; dependency on caregiver for daily activities; professional application of fluoridated products in the last 3 months; diagnoses of cardiac, renal, gastrointestinal, hepatic, pulmonary, neurological, psychiatric, hematological or metabolic pathologies.

Design outcomes

Primary

MeasureTime frame
It is expected that the use of red propolis dentifrice associated with fluoride will demonstrate a clinical efficacy superior to fluoridated dentifrice and similar to Parodontax and Periogard.

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactMara Lotif

Universidade Federal do Ceará

mara_lotif@hotmail.com+55085997339834

Outcome results

None listed

Source: REBEC (via WHO ICTRP)